When you invest, your capital is at risk.

MRNA

Moderna, Inc.

About MRNA

Moderna, Inc. is a biotechnology company. The Company is focused on developing messenger ribonucleic acid (mRNA) therapeutics and vaccines. It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. The Company's products include Spikevax, the Moderna COVID-19 vaccine (mRNA-1273), a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax (mRNA-1273.214), and bivalent vaccine targeting the BA.4/BA.5 Omicron variants combined with Spikevax (mRNA-1273.222). It has a development pipeline of 45 development candidates across its 48 development programs, of which 38 are in clinical studies.

Market Capitalisation

$58.66B

Price-earnings ratio

-

Dividend yield

0.00%

Volume

2.82M

High today

$153.68

Low today

$148.07

Open price

$153.31

52-week high

$217.25

52-week low

$115.03


MRNA FAQs

One share of Moderna, Inc. is valued at 148,53 $.

The ticker symbol for Moderna, Inc. is MRNA.

To buy MRNA stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
  1. Sign up in minutes, all you need is some I.D.
  2. Choose Stake Wall St
  3. Deposit directly into your Stake wallet and you're ready to invest in MRNA

The Moderna, Inc. 52-week high stock price is 217,25 $.

The Moderna, Inc. 52-week low stock price is 115,03 $.

As of 23/03/2023 Moderna, Inc. has a market cap of $59 млрд.


Related Stocks

When you invest, your capital is at risk. The value of investments can go up as well as down and you may receive back less than your original investment. Any advice is of a general nature only. As all investments carry risk, before making any investment decision, consider if it's right for you and seek appropriate advice from a licensed tax or financial advisor. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.


Stake logo
Download Stake
App Store logo
Google Play logo
The value of your investments can go down as well as up, so you could get back less than your original investment. Any advice is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Please view our Terms & Conditions, Privacy Policy and Disclaimers before deciding to use or invest on Stake. By using the Stake website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake is the trading name of Hellostake Limited (no. 11676409), authorised and regulated by the UK Financial Conduct Authority (FRN: 830771).

Copyright © 2023 Stake. All rights reserved.